These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3514543)

  • 21. Early institution of bromocriptine in Parkinson's disease inhibits the emergence of levodopa-associated motor side effects. Long-term results of the PRADO study.
    Przuntek H; Welzel D; Gerlach M; Blümner E; Danielczyk W; Kaiser HJ; Kraus PH; Letzel H; Riederer P; Uberla K
    J Neural Transm (Vienna); 1996; 103(6):699-715. PubMed ID: 8836932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bromocriptine in Parkinson's disease: a double-blind study comparing "low-slow" and "high-fast" introductory dosage regimens in de novo patients. UK Bromocriptine Research Group.
    J Neurol Neurosurg Psychiatry; 1989 Jan; 52(1):77-82. PubMed ID: 2651567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Therapeutic effects of trazodone in the treatment of tremor. Multicentric double-blind study].
    Sanson F; Schergna E; Semenzato D; Trevisan CP; Bizzarini M; Violante F; Santagostino I; Ravenna C; Maccarone G
    Riv Neurol; 1986; 56(6):358-64. PubMed ID: 3296121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transdermal rotigotine: double-blind, placebo-controlled trial in Parkinson disease.
    Jankovic J; Watts RL; Martin W; Boroojerdi B
    Arch Neurol; 2007 May; 64(5):676-82. PubMed ID: 17502466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gabapentin for parkinsonism: a double-blind, placebo-controlled, crossover trial.
    Olson WL; Gruenthal M; Mueller ME; Olson WH
    Am J Med; 1997 Jan; 102(1):60-6. PubMed ID: 9209202
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of bornaprine in localized hyperhidrosis].
    Castells Rodellas A; Moragón Gordon M; Ramírez Bosca A
    Med Cutan Ibero Lat Am; 1987; 15(4):303-5. PubMed ID: 3320624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bromocriptine lessens the incidence of mortality in L-dopa-treated parkinsonian patients: prado-study discontinued.
    Przuntek H; Welzel D; Blümner E; Danielczyk W; Letzel H; Kaiser HJ; Kraus PH; Riederer P; Schwarzmann D; Wolf H
    Eur J Clin Pharmacol; 1992; 43(4):357-63. PubMed ID: 1451713
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transdermal nicotine in PD: a randomized, double-blind, placebo-controlled study.
    Vieregge A; Sieberer M; Jacobs H; Hagenah JM; Vieregge P
    Neurology; 2001 Sep; 57(6):1032-5. PubMed ID: 11571330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Eltoprazine counteracts l-DOPA-induced dyskinesias in Parkinson's disease: a dose-finding study.
    Svenningsson P; Rosenblad C; Af Edholm Arvidsson K; Wictorin K; Keywood C; Shankar B; Lowe DA; Björklund A; Widner H
    Brain; 2015 Apr; 138(Pt 4):963-73. PubMed ID: 25669730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Double-blind, single-dose, cross-over study of the effects of pramipexole, pergolide, and placebo on rest tremor and UPDRS part III in Parkinson's disease.
    Navan P; Findley LJ; Jeffs JA; Pearce RK; Bain PG
    Mov Disord; 2003 Feb; 18(2):176-80. PubMed ID: 12539211
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amitriptyline in the treatment of headache in patients with Parkinson's disease: a double-blind placebo-controlled study.
    Indaco A; Carrieri PB
    Neurology; 1988 Nov; 38(11):1720-2. PubMed ID: 3054626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Bromocriptin in the treatment of progressive stages of Parkinson's disease (author's transl)].
    Schneider E; Fischer PA
    Dtsch Med Wochenschr; 1982 Feb; 107(5):175-9. PubMed ID: 6799266
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyperhidrosis treatment with bornaprine in the acute phase of spinal cord-injured patients.
    Sergi R; Massone A; Moretto S; Oggerino C; Bertolotto F; Losio L; Ottonello M
    Spinal Cord; 2008 Aug; 46(8):571-3. PubMed ID: 18332889
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of methylphenidate on response to oral levodopa: a double-blind clinical trial.
    Nutt JG; Carter JH; Carlson NE
    Arch Neurol; 2007 Mar; 64(3):319-23. PubMed ID: 17353373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Double-blind comparison of pramipexole and bromocriptine treatment with placebo in advanced Parkinson's disease. International Pramipexole-Bromocriptine Study Group.
    Guttman M
    Neurology; 1997 Oct; 49(4):1060-5. PubMed ID: 9339690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acidrine in the management of gastritis and duodenitis. A double-blind placebo controlled clinical trial.
    Galeone M; Cacioli D; Toti GL; Moise G; Megevand J; Benazzi E; Michetti F
    J Int Med Res; 1984; 12(1):51-5. PubMed ID: 6363157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lamotrigine trial in idiopathic parkinsonism: a double-blind, placebo-controlled, crossover study.
    Shinotoh H; Vingerhoets FJ; Lee CS; Uitti RJ; Schulzer M; Calne DB; Tsui J
    Neurology; 1997 May; 48(5):1282-5. PubMed ID: 9153458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. AFQ056 in Parkinson patients with levodopa-induced dyskinesia: 13-week, randomized, dose-finding study.
    Stocchi F; Rascol O; Destee A; Hattori N; Hauser RA; Lang AE; Poewe W; Stacy M; Tolosa E; Gao H; Nagel J; Merschhemke M; Graf A; Kenney C; Trenkwalder C
    Mov Disord; 2013 Nov; 28(13):1838-46. PubMed ID: 23853029
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Budipine provides additional benefit in patients with Parkinson disease receiving a stable optimum dopaminergic drug regimen.
    Przuntek H; Bittkau S; Bliesath H; Büttner U; Fuchs G; Glass J; Haller H; Klockgether T; Kraus P; Lachenmayer L; Müller D; Müller T; Rathay B; Sgonina J; Steinijans V; Teshmar E; Ulm G; Volc D
    Arch Neurol; 2002 May; 59(5):803-6. PubMed ID: 12020263
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bromocriptine in the treatment of Parkinson's disease: a double-blind study against L-dopa/carbidopa.
    Gawel M; Riopelle R; Libman I; Bouchard S
    Adv Neurol; 1987; 45():535-8. PubMed ID: 3548263
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.